Comparative Study
Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin
- PMID: 109189
Item in Clipboard
Comparative Study
Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin
Cancer Res.
1979 Jun.
Abstract
The abilities of the racemic trans-3,4-, 5,6-, and 8,9-dihydrodiols of 7,12-dimethylbenz(a)anthracene to initiate skin tumors in mice were determined by using a two-stage system of tumorigenesis. The 7,12-dimethylbenz(a)anthracene trans-3,4-dihydrodiol was found to be much more active as a tumor initiator than the parent hydrocarbon. The 7,12-dimethylbenz(a)anthracene trans-5,6- and 8,9-dihydrodiols were essentially inactive as skin tumor initiators. Our results suggest that the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene is a proximal carcinogen and that the "bay region" diol-epoxide may be the ultimate carcinogenic form of DMBA.
Similar articles
-
Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.J Natl Cancer Inst. 1982 Sep;69(3):725-8. J Natl Cancer Inst. 1982. PMID: 6810009
-
Carcinogenicity and mutagenicity of benz(a)anthracene diols and diol-epoxides.Cancer Res. 1978 Jun;38(6):1699-704. Cancer Res. 1978. PMID: 647680
-
Oxidation of the trans-3,4-dihydrodiol metabolites of the potent carcinogen 7,12-dimethylbenz(a)anthracene and other benz(a)anthracene derivatives by 3 alpha-hydroxysteroid-dihydrodiol dehydrogenase: effects of methyl substitution on velocity and stereochemical course of trans-dihydrodiol oxidation.Cancer Res. 1988 Mar 1;48(5):1227-32. Cancer Res. 1988. PMID: 3124956
-
The importance of the "bay region" diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis.Cancer Lett. 1979 Apr;6(4-5):213-20. doi: 10.1016/s0304-3835(79)80036-1. Cancer Lett. 1979. PMID: 108011
-
Biotransformation and bioactivation of 7, 12-dimethylbenz[a]anthracene (7, 12-DMBA).Drug Metab Rev. 1980;11(1):61-101. doi: 10.3109/03602538008994022. Drug Metab Rev. 1980. PMID: 6775921 Review.
Cited by
-
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.Mol Aspects Med. 2014 Apr;36:1-55. doi: 10.1016/j.mam.2013.08.002. Epub 2013 Aug 30. Mol Aspects Med. 2014. PMID: 23994691 Free PMC article. Review.
-
Metabolism and activation of chemical carcinogens.Mol Cell Biochem. 1980 Sep 15;32(2):95-104. doi: 10.1007/BF00227802. Mol Cell Biochem. 1980. PMID: 6161301 Review.
-
Combined deletion of p38γ and p38δ reduces skin inflammation and protects from carcinogenesis.Oncotarget. 2015 May 30;6(15):12920-35. doi: 10.18632/oncotarget.4320. Oncotarget. 2015. PMID: 26079427 Free PMC article.
-
Polycyclic aromatic hydrocarbons and possible metabolites: convertogenic activity in yeast and tumor initiating activity in mouse skin.J Cancer Res Clin Oncol. 1981;102(2):127-39. doi: 10.1007/BF00410664. J Cancer Res Clin Oncol. 1981. PMID: 7338531 Free PMC article.
-
Metabolism of 7,12-dimethylbenzanthracene (DMBA) by mouse skin keratinocytes, fibroblasts, and carcinoma cells in culture.Arch Toxicol. 1980 Mar;44(1-3):181-95. doi: 10.1007/BF00303195. Arch Toxicol. 1980. PMID: 6770796 No abstract available.